Bruker
PreOmics Closes €13.5M Series B Financing Round
Bruker was the sole investor in the round and bought out several previous PreOmics investors in a secondary transaction to become a majority investor in the firm.
JPM Healthcare Conference Day 1: Seer, Twist, 10x, Guardant, Natera, Bruker, Adaptive, Qiagen, Sema4
Highlights of the first day included updates on Seer's new proteomics platform and a new enzymatic DNA synthesis chemistry from Twist Bioscience.
Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021
While Fulgent's stock price nearly doubled, at the other end of the spectrum, Berkeley Lights saw an 80 percent decline in its share price.
Bruker, Cellenion Ink Comarketing Agreement for Single-Cell Proteomics
Under the agreement, the firms will pair Cellenion's cellenOne single-cell isolation and dispensing system with Bruker's timsTOF SCP mass spectrometer.
Bruker Posts 19 Percent Jump in Q3 Revenues
The company's Q3 2021 revenues were $608.9 million, up from $511.4 million in Q3 2020 and beating the consensus Wall Street estimate of $575.2 million.
Aug 2, 2021
Bruker Posts 34 Percent Jump in Q2 Revenues
Jun 18, 2021
May 5, 2021
Bruker Posts 31 Percent Jump in Q1 Revenues
Mar 18, 2021
Bruker Invests in Startup Acuity Spatial Genomics
Mar 10, 2021
Feb 16, 2021
Bruker Q4 Revenues up 5 Percent
Dec 3, 2020
Sep 25, 2020
Sep 11, 2020